File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1158/1078-0432.CCR-17-3588
- Scopus: eid_2-s2.0-85053740236
- WOS: WOS:000446207700005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
| Title | Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma |
|---|---|
| Authors | |
| Issue Date | 2018 |
| Publisher | American Association for Cancer Research. The Journal's web site is located at http://clincancerres.aacrjournals.org/ |
| Citation | Clinical Cancer Research, 2018, v. 24, p. 4650-4661 How to Cite? |
| Persistent Identifier | http://hdl.handle.net/10722/264221 |
| ISSN | 2021 Impact Factor: 13.801 2020 SCImago Journal Rankings: 5.427 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lim, HY | - |
| dc.contributor.author | Merle, P | - |
| dc.contributor.author | Weiss, KH | - |
| dc.contributor.author | Yau, TCC | - |
| dc.contributor.author | Ross, P | - |
| dc.contributor.author | Mazzaferro, V | - |
| dc.contributor.author | Blanc, JF | - |
| dc.contributor.author | Ma, YT | - |
| dc.contributor.author | Yen, CJ | - |
| dc.contributor.author | Kocsis, J | - |
| dc.contributor.author | Choo, SP | - |
| dc.contributor.author | Sukeepaisarnjaroen, W | - |
| dc.contributor.author | Gérolami, R | - |
| dc.contributor.author | Dufour, JF | - |
| dc.contributor.author | Gane, EJ | - |
| dc.contributor.author | Ryoo, BY | - |
| dc.contributor.author | Peck-Radosavljevic, M | - |
| dc.contributor.author | Dao, T | - |
| dc.contributor.author | Yeo, W | - |
| dc.contributor.author | Lamlertthon, W | - |
| dc.contributor.author | Thongsawat, S | - |
| dc.contributor.author | Teufel, M | - |
| dc.contributor.author | Roth, K | - |
| dc.contributor.author | Reis, D | - |
| dc.contributor.author | Childs, BH | - |
| dc.contributor.author | Krissel, H | - |
| dc.contributor.author | Llovet, JM | - |
| dc.date.accessioned | 2018-10-22T07:51:29Z | - |
| dc.date.available | 2018-10-22T07:51:29Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Clinical Cancer Research, 2018, v. 24, p. 4650-4661 | - |
| dc.identifier.issn | 1078-0432 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/264221 | - |
| dc.language | eng | - |
| dc.publisher | American Association for Cancer Research. The Journal's web site is located at http://clincancerres.aacrjournals.org/ | - |
| dc.relation.ispartof | Clinical Cancer Research | - |
| dc.title | Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma | - |
| dc.type | Article | - |
| dc.identifier.email | Yau, TCC: tyaucc@hku.hk | - |
| dc.identifier.authority | Yau, TCC=rp01466 | - |
| dc.description.nature | link_to_subscribed_fulltext | - |
| dc.identifier.doi | 10.1158/1078-0432.CCR-17-3588 | - |
| dc.identifier.scopus | eid_2-s2.0-85053740236 | - |
| dc.identifier.hkuros | 294255 | - |
| dc.identifier.volume | 24 | - |
| dc.identifier.spage | 4650 | - |
| dc.identifier.epage | 4661 | - |
| dc.identifier.isi | WOS:000446207700005 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 1078-0432 | - |